Abstract
Most patients with male pseudohermaphroditism (MPH) due to 17-ketosteroid reductase (17-KSR) deficiency were diagnosed at or after puberty when significant virilization occurred. We report 2 prepubertal sibs (Case 1, 4 yr and Case 2, 10 yr) unambiguously raised as females, with clitoral enlargement, separate urethral and vaginal orifices and gonads palpable at the inguinal canal bilaterally. Basal serum LH, FSH, 17-hydroxyprogesterone, testosterone (T), Dihydrotestosterone and dehydroepiandrosterone (DHEA) were normal for age. †4-Androstenedione (†4-A) was slightly elevated in Case 2 but nondiagnostic. Steroid measurements after human chorionic gonadotropin (hCG) stimulation were compared with those of boys with male external genitalia submitted to the same hCG protocol: peak T was subnormal (Case 1, 80, Case 2, 91, vs normal 329 ± 129 ng/dl, mean ± 1SD), peak †4-A elevated (Case 1, 477, Case 2,264, vs normal 44 ± 26 ng/dl) resulting in an abnormally elevated †4-A/T ratio (Case 1, 6.0, Case 2,2.9, vs normal 0.12 ± 0.09) and establishing the diagnosis of 17-KSR deficiency. This diagnosis was confirmed in vitro by minimal T production when testicular tissue of both patients was incubated with tritiated †4-A. The 2 sibs did not share a single haplotype for the HLA complex indicating lack of association between HLA and the locus of the gene for 17-KSR. In conclusion, in 2 sibs with MPH the subnormal T and elevated †4-A response to the hCG test indicated the diagnosis of 17-KSR deficiency followed by orchiectomy to avoid later virilization at puberty.
Similar content being viewed by others
References
Forest M.G. Inborn errors of testosterone biosynthesis. In: Josso N. (Ed.), The Intersex child. Karger, Basel, 1981, p. 133.
Virdis R., Saenger P. 17-Hydroxysteroid dehydrogenase deficiency. In: Levine L., New M.I., (Eds.), Adrenal diseases in childhood. Karger, Basel, 1984, p. 110.
Ulloa-Aguirre A., Bassol S., Poo J., Mendez J.P., Mutchinick O., Robles C., Pérez-Palacios G. Endocrine and biochemical studies in a 46, XY phenotypically male infant with 17-ketosteroid reductase deficiency. J. Clin. Endocrinol. Metab. 60: 639, 1985.
Imperato-McGinley J., Peterson R.E., Stoller R., Goodwin W.E. Male pseudohermaphroditism secondary to 17 β-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J. Clin. Endocrinol. Metab. 49: 391, 1979.
Rösier A., Kohn G. Male pseudohermaphroditism due to 17 β-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J. Steroid Biochem. 19: 663, 1983.
Levine L.S., Lieber E., Pang S., New M.I. Male pseudohermaphroditism due to 17-ketosteroid reductase deficiency diagnosed in the newborn period. Abstract 329. Pediatr. Res. 14: 480, 1980.
Harkness R.A., Thistlethwaite D., Darling J.A.B., Skakkebaek N.E., Corker CS. 17 β-hydroxysteroid oxidoreductase deficiency causing male pseudohermaphroditism in a child. J. Endocrinol. 67: 16 P, 1975.
Balducci R., Toscano V., Wright F., Bozzolan F., Di Piero G., Maroder M., Panei P., Sciarra F., Boscherini B. Familial male pseudohermaphroditism with gynaecomastia due to 17 β-hydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin. Endocrinol. (Oxf.) 23: 439, 1985.
Gross D.J., Landau H., Kohn G., Farkas A., Elrayyes E., El-Shawwa R., Lasch E., Rösler A. Male pseudohermaphroiditism due to 17 β-hydroxysteroid dehydrogenase deficiency: gender reassignment in early infancy. Acta Endocrinol. (Copenh.)112: 238, 1986.
Abraham G.E. Radioimmunoassay of steroids in biological materials. Acta Endocrinol. (Suppl. 183) (Copenh.) 75: 1, 1974.
Goldman A.S., Baker M.K., Stanek A.E. Development of †5-3-hydroxysteroid and glucose-6-phosphate dehydrogenase in the testis, adrenal and ovaries of the rabbit fetus. Proc. Soc. Exp. Biol. 140: 1486, 1972.
Wilson J.D., Walker J.D. The conversion of testosterone to dihydrotestosterone by skin slices of man. J. Clin. Invest. 48: 371, 1969.
Mittal K.K., Mickey M.R., Singal D.P., Terasaki P.I. Refinement of microdroplet lymphocyte cytotoxicity test. Transpianation 6: 913, 1968.
Forest M.G., David M., Lecoq A., Jeune M., Bertrand J. Kinetics of the hCG-induced steroidogenic response of the human testis. III. Studies in children of the plasma levels of testosterone and hCG: rationale for testicular stimulation test. Pediatr. Res. 14: 819, 1980.
Peterson R.E, Imperato McGinley J. Male pseudohermaphroditism due to deficiencies of testosterone biosynthesis. In: Serio M., Motta M., Zanisi M., Martini L. (Eds.), Sexual differentiation: basic and clinical aspects. Raven Press, New York, 1984, p. 301.
Saez J.M., Morera A.M., DePeretti E., Bertrand J. Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization). J. Clin. Endocrinol. Metab. 34: 598, 1972.
Givens J.R, Wiser W.L., Summit R.L., Kerber I.J., Andersen R.N., Pittaway D.E., Fish S.A. Familial male pseudohermaphroditism without gynecomastia due to deficient testicular 17-ketosteroid reductase activity. N.Engl. J. Med. 291: 938, 1974.
Saez J.M., De Peretti E., Morera A.M., David M., Bertrand J. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J. Clin. Endocrinol. Metab. 32: 604, 1971.
Tourniaire J., Laubie B., Saez J., Leung T.K., Perrin J, Dutrieux N., Guinet P. Pseudohermaphrodisme mâle familial par deficit testiculaire en 17-cetostéroide-réductase. Ann. Endocrinol. (Paris) 34: 461, 1973.
Forest M.G., De Peretti E., Campo-Paysaa A. Cas familial de pseudo-hermaphroidisme masculin par déficit en 17-ceto-réductase: diagnostic tardif chez la “tante” d’un sujet porteur du même déficit. Ann. Endocrinol. (Paris) 40: 545, 1979.
Goebelsmann U., Horton R., Mestman J.H., Arce J.J., Nagata Y., Nakamura R.M., Thorneycroft I.H., Mishell Jr D.R. Male pseudohermaphroditism due to testicular 17-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 36: 867, 1973.
Lanes R., Brown T.R., Gruber de Bustos E., Valverde B., Pieretti R.B., Bianco N., Ortega G., Migeon C.J. Sibship with 17-ketosteroid reductase (17-KSR) deficiency and hypothyroidism. Lack of linkage of histocompatibility leucocyte antigen and 17-KSR loci. J. Clin. Endocrinol. Metab. 57: 190, 1983.
Goebelsmann U., Hall T.D., Paul W.L., Stancyk F.Z. In vitro steroid metabolic studies in testicular 17 β-reduction deficiency. J. Clin. Endocrinol. Metab. 41: 1136, 1975.
Guénet J.L. Don non-linked genes really reassort at random? Ann. Inst. Pasteur/Immunol. 136 C: 85, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arnhold, I.J.P., Mendonça, B.B., Diaz, J.A.P. et al. Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association. J Endocrinol Invest 11, 319–322 (1988). https://doi.org/10.1007/BF03350158
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350158